SCHEMBL16506540

SCHEMBL16506540

C=CC[C@@H](NP(=O)(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ TSHR P16473 9/20 0.49
▸ CYP3A4 P08684 8/20 0.49
▸ LMNA P02545 3/20 0.49
▸ MAPT P10636 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ ALOX15 P16050 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ MAPK1 P28482 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP2C19 P33261 3/20 0.44
▸ CYP2C9 P11712 5/20 0.43
▸ CYP2D6 P10635 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ TP53 P04637 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15232376 0.91 SMN1; SMN2 (0.43) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL15242584 0.91 SMN1; SMN2 (0.43) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL16521856 0.90 CYP3A4 (0.44) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL16506084 0.86 KCNA5 (0.49) SMN1; SMN2TSHRCYP3A4LMNAMAPK1
SCHEMBL16506129 0.86 CYP3A4 (0.51) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL16505815 0.86 CYP3A4 (0.42) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL16506356 0.86 CYP3A4 (0.49) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL16521842 0.84 CYP3A4 (0.47) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL15232461 0.83 TSHR (0.53) SMN1; SMN2TSHRCYP3A4LMNAMAPT
SCHEMBL17722013 0.81 SMN1; SMN2 (0.50) SMN1; SMN2TSHRCYP3A4LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9328061-B2 Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols TRUSTEES OF BOSTON COLLEGE (US) 2016-05-03 — — US disclosed
US-9328061-B2 Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols TRUSTEES OF BOSTON COLLEGE (US) 2016-05-03 — — US disclosed
US-20150057451-A1 SIMPLE ORGANIC MOLECULES AS CATALYSTS FOR PRACTICAL AND EFFICIENT ENANTIOSELECTIVE SYNTHESIS OF AMINES AND ALCOHOLS NATIONAL INSTITUTES OF HEALTH, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT 2015-02-26 — — US disclosed
US-20150057451-A1 SIMPLE ORGANIC MOLECULES AS CATALYSTS FOR PRACTICAL AND EFFICIENT ENANTIOSELECTIVE SYNTHESIS OF AMINES AND ALCOHOLS NATIONAL INSTITUTES OF HEALTH, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT 2015-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057451-A1 SIMPLE ORGANIC MOLECULES AS CATALYSTS FOR PRACTICAL AND EFFICIENT ENANTIOSELECTIVE SYNTHESIS OF AMINES AND ALCOHOLS ADH1C, ADH5, ADH1A SMN1; SMN2 3486/4885TSHR 1559/4885CYP3A4 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback